OSANG Healthcare secures FDA approval for COVID-19 and flu test kit in U.S.
Media Center
Infopia, first-half sales increased 15% year-on-year with “additional paid-in-capital increase in the process.”
Healthcare specialist Infopia has announced that its first-half sales increased 15% compared with the year prior, after acquisition by Osang Jaiel.
An official from Infopia said that first-half sales were 28 billion KRW, an increase of 15% compared with last year’s results, and that annual sales were expected to exceed 60 billion KRW, a prospective increase of 20%….
Related posts
